Dupont De Nemours Inc (DD)
DuPont Completes Qnity™ Board of Directors
DuPont Completes Qnity™ Board of Directors
vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series
uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
Ocugen To Present at BIO International Convention 2025
BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)
Cybin - Cybin to Participate in the 2025 Psychedelic Science Conference
BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
Cybin to Participate in the 2025 Psychedelic Science Conference